According to Lu Xin Venture Capital's announcement, the cumulative deviation value of the company's stock price increase reached 20% for three consecutive trading days from December 23 to 25, 2025, which is an abnormal fluctuation. The stock price increased cumulatively by 40.48% from 23 to 26, and stopped on the 26th. The company's latest rolling price-earnings ratio is 91.00 times and the net price-earnings ratio is 3.32 times, which is significantly higher than the industry level. Up to now, the three participating funds only hold 0.89% of Blue Rocket's shares in total, which has had little impact. The controlling shareholders have disclosed plans to reduce their holdings. The directors, supervisors, and controlling shareholders did not trade the company's shares during this period of abnormal fluctuations, reminding investors to be aware of the risks.

According to Lu Xin Venture Capital's announcement, the cumulative deviation value of the company's stock price increase reached 20% for three consecutive trading days from December 23 to 25, 2025, which is an abnormal fluctuation. The stock price increased cumulatively by 40.48% from 23 to 26, and stopped on the 26th. The company's latest rolling price-earnings ratio is 91.00 times and the net price-earnings ratio is 3.32 times, which is significantly higher than the industry level. Up to now, the three participating funds only hold 0.89% of Blue Rocket's shares in total, which has had little impact. The controlling shareholders have disclosed plans to reduce their holdings. The directors, supervisors, and controlling shareholders did not trade the company's shares during this period of abnormal fluctuations, reminding investors to be aware of the risks.